secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Essence Corp (BIOE)
CIK:        0001723059
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001213900-26-047207
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio Essence acquires MediFlow AI software for $3.5M in restricted stock
-----------------------------------------------------------------------

- Bio Essence (BIOE) entered an Asset Purchase Agreement to buy the MediFlow AI (formerly AcuVital) platform from Zhituo Software.
- Purchase price is $3.5 million in restricted common stock, valued at fair market value as determined by BIOE's board.
- Closing is expected within 45 days of April 20, 2026, subject to board approval and delivery of assignment documents.
- Seller Zhituo Software Co., Limited is a Hong Kong company with no prior relationship to BIOE.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723059/000121390026047207/0001213900-26-047207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723059/000121390026047207/ea0287548-8k_bioessence.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-047207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer